Is a complete HEL/TTALO research report available?

Question

Accepted Answer

No complete published report is available for hel/TTALO (HEL/TTALO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Market cap	959.9M
Revenue (ttm)	1.2B
Net income (ttm)	67.9M
EPS (ttm)	€0.53
Shares out	126.8M
P/E (trailing)	14.3x
P/E (forward)	10.8x
Dividend	€0.64 (8.45%)
Volume	0

Metric	Value
Country	Finland
Country code	FI
Employees	7,698
Employees Change	-1,101%
Employees Change Percent	-12.51
Enterprise value	EUR 1.5B
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	FI4000252127
Last refreshed	2026-08-02
Market cap	EUR 959.9M
Price	EUR 7.57
Price currency	EUR
Rev Per Employee	157,430.5x
Sector	Healthcare
Sector PE	21.97
Sector PE Fwd	18.66
Sic	8090
Symbol	hel/TTALO
Website	https://www.terveystalo.com

Metric	Value
Earnings Yield	7.07%
EV Earnings	22.38x
EV/EBIT	14.14x
EV/EBITDA	7.26x
EV/FCF	10.36x
EV/Sales	1.25x
FCF yield	15.28%
Forward P/E	10.79x
P/B ratio	1.81x
P/E ratio	14.26x
P/S ratio	0.79x
PE Ratio10 Y	33.26x
PE Ratio3 Y	17.65x
PE Ratio5 Y	32.14x
PEG ratio	10.79x

Metric	Value
EBIT Margin	8.87%
EBITDA Margin	17.28%
FCF margin	12.1%
Gross margin	27.96%
Gross Profit	EUR 338.9M
Gross Profit Growth	-7.83%
Gross Profit Growth Q	-12.99%
Gross Profit Growth3 Y	5.91%
Gross Profit Growth5 Y	4.58%
Net Income	EUR 67.9M
Net Income Growth	-24.05%
Net Income Growth Q	-37.84%
Net Income Growth Years	2%
Net Income Growth3 Y	117.49%
Net Income Growth5 Y	-2.88%
Pretax Margin	7.1%
Profit Margin	5.6%
Profit Per Employee	EUR 8,820
Profitable Quarters	EUR 10
Profitable Years	2
ROA	5.23
Roa5y	4.57
ROCE	10.03
ROE	12.61
Roe5y	7.98
ROIC	8.75
Roic5y	7.81

Metric	Value
Cagr1y	-24.7%
Cagr3y	5.48%
Cagr5y	-4.24%
Div CAGR3	31.73%
Div CAGR5	19.74%
EPS Growth	-24.83
EPS Growth Q	-35.99
EPS Growth Years	2
EPS Growth3 Y	118.8
EPS Growth5 Y	-2.38
FCF Growth	-13.35%
FCF Growth Q	1.45%
FCF Growth3 Y	8.64%
FCF Growth5 Y	0.82%
OCF Growth	-11.62%
OCF Growth Q	-5.43%
OCF Growth10 Y	11.62%
OCF Growth3 Y	6.94%
OCF Growth5 Y	2.68%
Revenue Growth	-8.06x
Revenue Growth Q	-8.77x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.67x
Revenue Growth5 Y	2.45x

HEL/TTALO (HEL/TTALO)

Coverage state: Market snapshot only — no published research

Generate the first HEL/TTALO analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · HEL/TTALO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HEL/TTALO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on HEL/TTALO

Frequently asked questions

Metric	Value
Asset Turnover	EUR 0.85
Assets	EUR 1.4B
Cash	EUR 87.5M
Current Assets	EUR 224.8M
Current Liabilities	EUR 367.4M
Debt	EUR 647.4M
Debt EBITDA	EUR 3.09
Debt Equity	EUR 1.22
Debt FCF	EUR 4.41
Equity	EUR 531.8M
Interest Coverage	5.12
Liabilities	EUR 907.3M
Long Term Assets	EUR 1.2B
Long Term Liabilities	EUR 539.9M
Net Cash	EUR -559.9M
Net Cash By Market Cap	EUR -58.33
Net Debt EBITDA	EUR 2.67
Net Debt Equity	EUR 1.05
Net Debt FCF	EUR 3.82
Tangible Book Value	EUR -387.8M
Tangible Book Value Per Share	EUR -3.06
WACC	4.79

Metric	Value
Current ratio	0.61
Inventory Turnover	110.5
Net Working Capital	EUR -87.6M
Quick ratio	0.59
Working Capital	EUR -142.6M
Working Capital Turnover	EUR -9.28

Metric	Value
Buyback Yield	-0.86%
Dividend Growth	33.33%
Dividend Growth Years	2%
Dividend per share	EUR 0.64
Dividend Years	9
Dividend Yield	8.45%
Ex Div Date	2026-10-07
Last Dividend	EUR 0.32
Payout Frequency	Semi-Annual
Payout Ratio	104.57%

Metric	Value
1Y total return	-24.69%
200-day SMA	8.8
3Y total return	17.37%
50-day SMA	7.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-19.48%
All Time High	12.66
All Time High Change	-40.21%
All Time High Date	2020-01-23
All Time Low	5.96
All Time Low Change	27.01%
All Time Low Date	2022-11-03
ATR	0.22
Beta	0.37
Beta1y	0.35
Beta2y	0.45
Ch YTD	-22.6
High	7.74
High52	10.88
High52 Date	2025-08-25
High52ch	-30.42%
Low	7.54
Low52	6.45
Low52 Date	2026-07-15
Low52ch	17.36%
Ma50ch	-0.42%
Price vs 200-day SMA	-13.97%
RSI	55.64
RSI Monthly	36.08
RSI Weekly	38.09
Sharpe ratio	-1.25x
Sortino ratio	-1.27
Total Return	7.65%
Tr YTD	-19.72
Tr1m	-1.17%
Tr1w	7.22%
Tr3m	-2.95%

Metric	Value
Analyst Count	2
Analyst Ratings	Hold
Operating Income	EUR 118.8M
Operating Income Growth	-14.29
Operating Income Growth Q	-30.75
Operating Income Growth3 Y	27.22
Operating Income Growth5 Y	1.76
Operating margin	9.8
Price target	EUR 8.75
Price Target Change	EUR 15.59

Metric	Value
Float	105,619,801%
Net Borrowing	18,300,000
Shares Insiders	0.17%
Shares Institutions	53.66%
Shares Out	126,809,464
Shares Qo Q	0.08%
Shares Yo Y	0.86%

Metric	Value
Average Volume	215,822.4x
Bv Per Share	4.19
CAPEX	EUR -28.3M
Ch1m	-1.17
Ch1w	7.22
Ch1y	-29.12
Ch3m	-2.95
Ch3y	2.44
Ch5y	-33.94
Ch6m	-25.35
Change	0.66%
Change From Open	0.4
Close	7.52
Days Gap	0.27
Depreciation Amortization	45,200,000
Earnings Date	2026-07-17
EBIT	EUR 107.5M
EBITDA	EUR 209.4M
EPS	EUR 0.53
F Score	5
FCF	EUR 146.7M
FCF EV Yield	9.65x
FCF Per Share	EUR 1.16
Financing CF	-71,800,000
Fiscal Year End	December
Founded	2,001
Goodwill	837,400,000
Graham Number	7.0768
Graham Upside	-6.52
Income Tax	EUR 18.1M
Investing CF	-66,600,000
Is Primary Listing	1
Last Earnings Date	2026-07-17
Last Report Date	2026-06-30
Lynch Fair Value	EUR 2.65
Lynch Upside	-64.94
Ma150	8.61
Ma150ch	-12.03%
Ma20	7.35
Ma20ch	2.95%
Net CF	36,000,000
Next Earnings Date	2026-10-23
Open	7.54
P FCF Ratio	6.54
P OCF Ratio	5.49
Payment Date	2026-10-15
Position In Range	15
Ppne	277,600,000
Price Date	2026-07-31
Price EBITDA	EUR 4.58
Relative Volume	2.26x
Revenue	1,211,900,000x
Tax By Revenue	1.49x
Tax Rate	21.05%
Tr6m	-22.57%
Volume	0
Z Score	1.83